• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Oxygenta Pharmaceutical Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 19443.0
  • ISIN : INE102E01018
101.10 -5 (-4.44%)
  • As on 02 Aug 2025 (EOD)
  • Today’s Low

    100.60
  • Today’s High

    107.95
  • Open

    100.60
  • Perv Close

    105.80
  • 52W Low

    31.01
  • 52W High

    133.50

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    373.90

  • Div & Yield %

    0.00

  • Book Value(₹)

    -6.93

  • Debt-Equity Ratio

    -4.44

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    373.90

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    36.98

  • BV (₹)

    -6.90

  • Sales( ₹ in Cr.)

    109.30

  • NP (in Cr.)

    -10.03

  • NP Var(%)

    -185.0

  • Div%

    0.0

  • CPS (₹)

    -1.70

  • EPS (₹)

    -2.70

  • Traded Value (₹ in Lakhs)

    373.90

  • 52 Week High

    133.50

  • 52 Week Low

    31.01

  • Price BSE

    101.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    373.90

  • P/C Ratio

    -58.20

  • P/E Ratio

    -37.20

  • Price Vs.BV

    -2.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 39.64 30.99 60.52 52.03 13.72 20.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 39.64 30.99 60.52 52.03 13.72 20.51
Other Income 0.10 0.14 1.36 2.28 4.02 0.31
Stock Adjustments 1.53 4.63 -4.55 6.39 -0.59 1.67
Total Income 41.27 35.76 57.33 60.70 17.15 22.49
EXPENDITURE :            
Raw Materials 35.06 28.64 42.67 43.02 14.99 17.75
Power and Fuel Cost 4.15 4.16 3.04 2.79 1.00 0.89
Employee Cost 5.87 5.74 0.58 4.08 2.50 2.71
Other Manufacturing Expenses 3.28 2.43 6.31 2.88 1.32 1.38
Selling and Administration Expenses 2.48 1.75 1.88 1.79 1.17 1.43
Miscellaneous Expenses 0.04 0.87 0.82 0.01 0.01 0.06
Employee Benefit Expenses 5.87 5.74 0.58 4.08 2.50 2.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 50.89 43.59 55.31 54.57 20.99 24.22
Operating Profit -9.62 -7.83 2.02 6.12 -3.85 -1.72
Interest 1.59 1.49 0.92 1.78 1.09 0.75
Gross Profit -11.21 -9.32 1.10 4.34 -4.94 -2.47
Depreciation 2.66 2.05 1.59 1.20 1.00 1.02
Profit Before Tax -13.87 -11.37 -0.49 3.14 -5.94 -3.49
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.39 0.20 0.12 0.21 -0.15 -0.24
Reported Net Profit -3.48 -11.57 -0.61 2.93 -5.79 -3.25
Extraordinary Items 0.04 -0.72 0.43 2.04 3.99 0.00
Adjusted Net Profit -3.52 -10.85 -1.04 0.89 -9.78 -3.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -60.40 -48.83 -48.22 -51.15 -45.36 -42.11
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -63.88 -60.40 -48.83 -48.22 -51.15 -45.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.04 -8.15 -0.43 2.87 -5.67 -3.19
Earnings Per Share(Adj)-Unit Curr -1.04 -8.15 -0.43 - - -
Book Value -6.18 -32.53 -24.38 -37.27 -40.14 -34.47
Book Value(Adj)-Unit Curr -6.18 -32.53 -24.38 - - -

Shareholding Pattern

  • Promoter Group

    57.92%

  • Public Share Holding

    42.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 20,477,458 55.37 20,477,458 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 942,700 2.55 942,700 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,420,158 57.92 21,420,158 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 9,700 0.03 0 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,700 0.03 0 3
2] Non Institution
Bodies Corporate 95,908 0.26 78,208 70
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,702,399 4.60 1,700,399 19
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 198,637 0.54 198,637 49
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,846,834 29.33 10,846,834 46
Individuals holding nominal share capital up to Rs. 1 lakh 2,706,463 7.32 1,437,033 9,899
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,553,642 42.06 14,264,512 10,086
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 36,983,500 100.00 35,684,670 10,094

Company Background

Oxygenta Pharmaceutical LtdPharmaceuticals - Indian - Bulk Drugs

  • Oxygenta Pharmaceutical Ltd
  • BSE Code : 19443.0
  • ISIN : INE102E01018
  • Incorporation Year

    1990

  • Registered Office

    Survey No 252/1 Aroor Village
    Sadasivapet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-08455-250080/250280

  • FAX

    91-08455-250090

  • Chairman

    Sai Sudhakar Vankineni

  • Managing Director

    Sai Sudhakar Vankineni

  • Company Secretary

    Dolly Mandhan

  • Auditor

    A M Reddy & D R Reddy

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Oxygenta Pharmaceutical Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Oxygenta Pharma 101.10 39.68 39.64 -36.37 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10